GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (NAS:BGXX) » Definitions » Debt-to-EBITDA

Bright Green (Bright Green) Debt-to-EBITDA : -0.35 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Bright Green Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bright Green's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.65 Mil. Bright Green's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.20 Mil. Bright Green's annualized EBITDA for the quarter that ended in Dec. 2023 was $-5.28 Mil. Bright Green's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.35.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Bright Green's Debt-to-EBITDA or its related term are showing as below:

BGXX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.23   Med: -0.22   Max: -0.18
Current: -0.22

During the past 4 years, the highest Debt-to-EBITDA Ratio of Bright Green was -0.18. The lowest was -0.23. And the median was -0.22.

BGXX's Debt-to-EBITDA is ranked worse than
100% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.66 vs BGXX: -0.22

Bright Green Debt-to-EBITDA Historical Data

The historical data trend for Bright Green's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Green Debt-to-EBITDA Chart

Bright Green Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
-0.18 -0.23 -0.22 -0.22

Bright Green Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.99 -0.52 -0.46 -0.25 -0.35

Competitive Comparison of Bright Green's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Bright Green's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bright Green's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bright Green's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bright Green's Debt-to-EBITDA falls into.



Bright Green Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bright Green's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.65 + 0.202) / -8.253
=-0.22

Bright Green's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.65 + 0.202) / -5.28
=-0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Bright Green  (NAS:BGXX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Bright Green Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bright Green's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bright Green (Bright Green) Business Description

Traded in Other Exchanges
N/A
Address
1033 George Hanosh Boulevard, Grants, NM, USA, 87020
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
Executives
Gurvinder Singh officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Saleem Elmasri officer: Chief Financial Officer 450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Seamus Mcauley officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson director, officer: Chief Executive Officer 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc. 10 percent owner 3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1

Bright Green (Bright Green) Headlines

From GuruFocus

Bright Green Operational Update

By Marketwired 08-10-2023

Bright Green Announces Pricing of $3.5 Million Private Placement

By sperokesalga sperokesalga 05-22-2023

Bright Green Announces Closing of $3.5 Million Private Placement

By sperokesalga sperokesalga 05-24-2023